(0.12%) 5 303.27 points
(0.34%) 40 004 points
(-0.07%) 16 686 points
(0.97%) $80.00
(5.73%) $2.64
(1.44%) $2 419.80
(6.36%) $31.78
(2.18%) $1 094.70
(-0.02%) $0.920
(-0.18%) $10.68
(-0.27%) $0.787
(0.19%) $91.05
2 days till quarter result
(bmo 2024-05-21)
Expected move: +/- 9.20%
Live Chart Being Loaded With Signals
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics...
Stats | |
---|---|
今日成交量 | 83 452.00 |
平均成交量 | 114 484 |
市值 | 14.88M |
EPS | $0 ( 2024-04-08 ) |
下一个收益日期 | ( $-0.310 ) 2024-05-21 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.420 |
ATR14 | $0.00800 (1.18%) |
音量 相关性
Mainz Biomed B.V. 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Mainz Biomed B.V. 相关性 - 货币/商品
Mainz Biomed B.V. 财务报表
Annual | 2023 |
营收: | $895 479 |
毛利润: | $509 659 (56.91 %) |
EPS: | $-1.620 |
FY | 2023 |
营收: | $895 479 |
毛利润: | $509 659 (56.91 %) |
EPS: | $-1.620 |
FY | 2022 |
营收: | $529 877 |
毛利润: | $182 151 (34.38 %) |
EPS: | $-1.870 |
FY | 2021 |
营收: | $577 348 |
毛利润: | $177 622 (30.77 %) |
EPS: | $-1.620 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Mainz Biomed B.V.
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。